OUR PRODUCTS

MOBILE APPS

GENERAL INFO

TCRX

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

TScan Therapeutics (TCRX) Earnings Date & Reports

TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

TCRX is expected to report earnings to rise 17.86% to -33 cents per share on November 05

TScan Therapeutics TCRX Stock Earnings Reports

Q3'25

Est.

$-0.33

Q2'25

Beat

by $0.05

Q1'25

Beat

by $0.54

Q4'24

Missed

by $0.01

Q3'24

Beat

by $0.06

The last earnings report on August 12 showed earnings per share of -28 cents, beating the estimate of -33 cents. With 190.90K shares outstanding, the current market capitalization sits at 94.51M.

View a ticker or compare two or three

Compare

TCRX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For TCRX
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. TCRX showed earnings on August 12, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

830 Winter Street

Phone

+1 857 399-9500

Employees

154

Web

https://www.tscan.com